ILAR category | Frequency | Definition |
Systemic JIA | 5%–15% | Arthritis in 1 or more joints with or preceded by fever of at least 2-week duration, documented to be daily for at least 3 days, and accompanied by 1 or more of the following:
|
Oligoarticular JIA | 30%–60% | Arthritis affecting 1–4 joints during the first 6 months of the disease 2 subcategories recognised:
|
Rheumatoid factor positive polyarticular JIA | 3%–7% | Arthritis affecting 5 or more joints during the first 6 months of disease with 2 or more positive tests for rheumatoid factor at least 3 months apart during the first 6 months of the disease |
Rheumatoid factor negative polyarticular JIA | 10%–25% | Arthritis affecting 5 or more joints during the first 6 months of disease with a negative rheumatoid factor test |
Enthesitis-related JIA | 5%–10% | Arthritis and/or enthesitis (sites where tendons or ligaments insert into the bone) with at least 2 of the following:
|
Psoriatic JIA | 3%–10% | Arthritis and psoriasis or arthritis and at least 2 of the following:
|
Undifferentiated JIA | 10%–20% | Arthritis that fulfils criteria in no category or in 2 or more of the above categories |
HLA, human leucocyte antigen; ILAR, International League Against Rheumatism; JIA, juvenile idiopathic arthritis.